Kerry Cormier

3.0k total citations
24 papers, 2.3k citations indexed

About

Kerry Cormier is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Kerry Cormier has authored 24 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 11 papers in Neurology. Recurrent topics in Kerry Cormier's work include Genetic Neurodegenerative Diseases (12 papers), Mitochondrial Function and Pathology (11 papers) and Amyotrophic Lateral Sclerosis Research (5 papers). Kerry Cormier is often cited by papers focused on Genetic Neurodegenerative Diseases (12 papers), Mitochondrial Function and Pathology (11 papers) and Amyotrophic Lateral Sclerosis Research (5 papers). Kerry Cormier collaborates with scholars based in United States, Switzerland and China. Kerry Cormier's co-authors include Karen Smith, Robert J. Ferrante, Hoon Ryu, Edward C. Stack, Steven J. Del Signore, Neil W. Kowall, Jae-Hwan Kim, Alpaslan Dedeoglu, Robert M. Friedlander and Bruce G. Jenkins and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and The Journal of Comparative Neurology.

In The Last Decade

Kerry Cormier

23 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kerry Cormier United States 18 1.4k 1.1k 627 502 221 24 2.3k
Anand Rane United States 21 944 0.7× 647 0.6× 826 1.3× 711 1.4× 416 1.9× 32 2.3k
Akiko Furuta Japan 26 1.3k 0.9× 1.1k 1.0× 474 0.8× 459 0.9× 282 1.3× 57 2.8k
Nadia Canu Italy 28 982 0.7× 732 0.6× 228 0.4× 882 1.8× 213 1.0× 43 2.0k
Patricia Cassina Uruguay 28 1.1k 0.8× 641 0.6× 1.3k 2.1× 652 1.3× 711 3.2× 45 2.9k
Molina Mhatre United States 22 580 0.4× 836 0.7× 308 0.5× 347 0.7× 404 1.8× 35 1.8k
Franco Onofri Italy 28 1.2k 0.9× 902 0.8× 364 0.6× 319 0.6× 307 1.4× 46 2.2k
Masaaki Waragai Japan 30 1.0k 0.7× 765 0.7× 1.2k 1.9× 1.0k 2.1× 466 2.1× 85 3.0k
Kari R. Hoyt United States 25 1.1k 0.8× 1.0k 0.9× 189 0.3× 390 0.8× 205 0.9× 42 2.1k
Sílvia Ginés Spain 30 2.0k 1.4× 1.9k 1.7× 548 0.9× 324 0.6× 243 1.1× 60 3.1k
Anita Sidhu United States 40 1.4k 1.0× 1.9k 1.7× 2.0k 3.2× 1.0k 2.1× 381 1.7× 86 4.0k

Countries citing papers authored by Kerry Cormier

Since Specialization
Citations

This map shows the geographic impact of Kerry Cormier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry Cormier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry Cormier more than expected).

Fields of papers citing papers by Kerry Cormier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerry Cormier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry Cormier. The network helps show where Kerry Cormier may publish in the future.

Co-authorship network of co-authors of Kerry Cormier

This figure shows the co-authorship network connecting the top 25 collaborators of Kerry Cormier. A scholar is included among the top collaborators of Kerry Cormier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerry Cormier. Kerry Cormier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cherry, Jonathan D., Weiming Xia, Sarah Daley, et al.. (2023). Vascular injury is associated with repetitive head impacts and tau pathology in chronic traumatic encephalopathy. Journal of Neuropathology & Experimental Neurology. 82(2). 127–139. 11 indexed citations
2.
3.
4.
Wang, Xin, Kerry Cormier, Karen Smith, et al.. (2011). The Melatonin MT1 Receptor Axis Modulates Mutant Huntingtin-Mediated Toxicity. Journal of Neuroscience. 31(41). 14496–14507. 156 indexed citations
5.
Faideau, Mathilde, Jae-Hwan Kim, Kerry Cormier, et al.. (2010). In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Human Molecular Genetics. 19(15). 3053–3067. 250 indexed citations
6.
Kim, Jae-Hwan, Jennifer P. Moody, Christina K. Edgerly, et al.. (2010). Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease. Human Molecular Genetics. 19(20). 3919–3935. 277 indexed citations
7.
Amante, Daniel J., Jin-Ho Kim, Samantha Carreiro, et al.. (2010). Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice. Amyotrophic Lateral Sclerosis. 11(6). 520–530. 16 indexed citations
8.
Lee, Junghee, Béla Kosaras, Kerry Cormier, et al.. (2010). Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington’s disease mice. Acta Neuropathologica. 121(4). 487–498. 139 indexed citations
9.
Choi, Ji‐Kyung, Bruce G. Jenkins, Isabel Carreras, et al.. (2009). Anti-inflammatory treatment in AD mice protects against neuronal pathology. Experimental Neurology. 223(2). 377–384. 49 indexed citations
10.
Yang, Lichuan, Noel Y. Calingasan, Elizabeth Wille, et al.. (2009). Combination therapy with Coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases. Journal of Neurochemistry. 109(5). 1427–1439. 188 indexed citations
11.
Wang, Xin, Shan Zhu, Irina G. Stavrovskaya, et al.. (2008). Inhibitors of CytochromecRelease with Therapeutic Potential for Huntington's Disease. Journal of Neuroscience. 28(38). 9473–9485. 100 indexed citations
12.
Stack, Edward C., Jin-Ho Kim, Steven J. Del Signore, et al.. (2008). Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1782(3). 151–162. 47 indexed citations
13.
Signore, Steven J. Del, Daniel J. Amante, Jin-Ho Kim, et al.. (2008). Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice. Amyotrophic Lateral Sclerosis. 10(2). 85–94. 84 indexed citations
14.
Stack, Edward C., Alpaslan Dedeoglu, Karen Smith, et al.. (2007). Neuroprotective Effects of Synaptic Modulation in Huntington's Disease R6/2 Mice. Journal of Neuroscience. 27(47). 12908–12915. 61 indexed citations
15.
Stack, Edward C., Ruth Luthi‐Carter, Byoung Yul Soh, et al.. (2007). Modulation of nucleosome dynamics in Huntington's disease. Human Molecular Genetics. 16(10). 1164–1175. 102 indexed citations
16.
Wang, Hongyan, Yingjun Guan, Xin Wang, et al.. (2007). Nortriptyline delays disease onset in models of chronic neurodegeneration. European Journal of Neuroscience. 26(3). 633–641. 50 indexed citations
17.
Smith, Karen, Samantha Matson, Wayne R. Matson, et al.. (2006). Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1762(6). 616–626. 111 indexed citations
18.
Stack, Edward C., Karen Smith, Hoon Ryu, et al.. (2005). Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1762(3). 373–380. 94 indexed citations
19.
Stack, Edward C., James K. Kubilus, Karen Smith, et al.. (2005). Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice. The Journal of Comparative Neurology. 490(4). 354–370. 200 indexed citations
20.
Dedeoglu, Alpaslan, Ji‐Kyung Choi, Kerry Cormier, Neil W. Kowall, & Bruce G. Jenkins. (2004). Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile. Brain Research. 1012(1-2). 60–65. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anand Rane Breakdown of academic impact, for papers by Akiko Furuta Breakdown of academic impact, for papers by Nadia Canu Breakdown of academic impact, for papers by Patricia Cassina Breakdown of academic impact, for papers by Molina Mhatre Breakdown of academic impact, for papers by Franco Onofri Breakdown of academic impact, for papers by Masaaki Waragai Breakdown of academic impact, for papers by Kari R. Hoyt Breakdown of academic impact, for papers by Sílvia Ginés Breakdown of academic impact, for papers by Anita Sidhu
Rankless by CCL
2026